HealthTree Logo
search more_vert
close
person Sign In / Create Account
RESCHEDULED: Real-World CAR-T Data Update
RESCHEDULED: Real-World CAR-T Data Update image
Immunotherapy (CAR T, Bispecifics and more) Treatment
event Mar 18, 2024 / 01:00PM - 02:00PM EDT

Event Description

Myeloma patients and their loved ones have been learning about the novel CAR-T therapies that are significantly improving myeloma care. A lot of the information we have comes from clinical trials. What are we learning in the clinic about CAR-T, including how older patients are responding, what long-term side effects look like, and more?

Come with your questions and get ready to learn with us!

Schedule & Agenda

The panelist Audrey Burton-Bethke
Introductions
1:00 PM
Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Sham Mailankody, MBBS.

The panelist Sham Mailankody, MBBS
Presentation
1:05 PM
Sham Mailankody, MBBS

Dr. Sham Mailankody discusses how real-world data is informing us about novel CAR-T therapies.

 

person
Questions and Answers
1:35 PM
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Sham Mailankody, MBBS
Sham Mailankody, MBBS

I am a medical oncologist specializing in the care of people with multiple myeloma and related plasma cell disorders. With my colleagues at Memorial Sloan Kettering Cancer Center (MSK), I am focused on identifying optimal treatment strategies for people with these disorders. My research focuses on the development of novel immune and cellular therapies, including chimeric antigen receptor (CAR) T cell therapies, for patients with myeloma. I also serve as the Clinical Director of the Cellular Therapy Service and the Research Director of the Myeloma Service at MSK.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube